Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Reesink

Showing results (51-60 of 250) with videos related to

Pageof 25
Sort By:
Journal of Medical Virology|November 1, 1987
Inactivation of 10(15) chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccineP N Lelie, H W Reesink, J Niessen, et al.
Transfusion|May 29, 2000
Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systemsM Beld, M R Habibuw, S P Rebers, et al.
Infusionstherapie Und Transfusionsmedizin|June 1, 1995
Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays: Wellcozyme VK45 and Ortho 2.0H Vrielink, C L van der Poel, H W Reesink, et al.
Lancet (London, England)|September 26, 1992
Prevention of Yersinia enterocolitica growth in red-blood-cell concentratesR N Pietersz, H W Reesink, W Pauw, et al.
Vox Sanguinis|January 1, 1995
Incorrect diagnosis of hepatitis C with RIBA-3M Damen, H Vrielink, P N Lelie, et al.
Vox Sanguinis|January 1, 1982
Removal of leukocytes from blood by fibre filtration. A comparison study on the performance of two commercially available filtersH W Reesink, H Veldman, H J Henrichs, et al.
Archives of Virology. Supplementum|January 1, 1992
HCV and blood transfusionH W Reesink, C L van der Poel, H T Cuypers, et al.
The New England Journal of Medicine|May 5, 1988
Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIVP N Lelie, H W Reesink, E Bakker, et al.
Vox Sanguinis|January 1, 1978
How should a carrier of hepatitis B surface antigen (HBsAg) be cared for with regard to clinical investigation, general counseling and occupational restrictions?L F Barker, S Iwarson, T Oda, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 1, 1998
[Optimal versus maximal safety of the blood transfusion chain in The Netherlands; results of a conference. College for Blood Transfusion of the Dutch Red Cross]C L van der Poel, J E de Boer, H W Reesink, et al.
Pageof 25

Showing results (51-60 of 250) with videos related to

Sort By:
Pageof 25
Journal of Medical Virology|November 1, 1987
Inactivation of 10(15) chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccineP N Lelie, H W Reesink, J Niessen, et al.
Transfusion|May 29, 2000
Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systemsM Beld, M R Habibuw, S P Rebers, et al.
Infusionstherapie Und Transfusionsmedizin|June 1, 1995
Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays: Wellcozyme VK45 and Ortho 2.0H Vrielink, C L van der Poel, H W Reesink, et al.
Lancet (London, England)|September 26, 1992
Prevention of Yersinia enterocolitica growth in red-blood-cell concentratesR N Pietersz, H W Reesink, W Pauw, et al.
Vox Sanguinis|January 1, 1995
Incorrect diagnosis of hepatitis C with RIBA-3M Damen, H Vrielink, P N Lelie, et al.
Vox Sanguinis|January 1, 1982
Removal of leukocytes from blood by fibre filtration. A comparison study on the performance of two commercially available filtersH W Reesink, H Veldman, H J Henrichs, et al.
Archives of Virology. Supplementum|January 1, 1992
HCV and blood transfusionH W Reesink, C L van der Poel, H T Cuypers, et al.
The New England Journal of Medicine|May 5, 1988
Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIVP N Lelie, H W Reesink, E Bakker, et al.
Vox Sanguinis|January 1, 1978
How should a carrier of hepatitis B surface antigen (HBsAg) be cared for with regard to clinical investigation, general counseling and occupational restrictions?L F Barker, S Iwarson, T Oda, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 1, 1998
[Optimal versus maximal safety of the blood transfusion chain in The Netherlands; results of a conference. College for Blood Transfusion of the Dutch Red Cross]C L van der Poel, J E de Boer, H W Reesink, et al.
Pageof 25